Central pharmacological activity of a new piperazine derivative: 4-(1-Phenyl-1h-pyrazol-4-ylmethyl)-piperazine-1-carboxylic acid ethyl ester

The compound LQFM008 showed anxiolytic-like activity which may involve serotonergic pathway.